Literature DB >> 16835786

Discordant response to ACTH stimulation in patients with septic shock.

Andrew Jones, Ian Webb, Toby Gibbs, Richard Beale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16835786     DOI： 10.1007/s00134-006-0227-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Cortisol changes among patients with septic shock and the relationship to ICU and hospital stay.

Authors:  Sergei Goodman; Charles L Sprung; Daniel Ziegler; Yoram G Weiss
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

2.  A single adrenocorticotropic hormone stimulation test does not reveal adrenal insufficiency in septic shock.

Authors:  Pekka Loisa; Ari Uusaro; Esko Ruokonen
Journal:  Anesth Analg       Date:  2005-12       Impact factor: 5.108

3.  Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

Authors:  P E Bollaert; C Charpentier; B Levy; M Debouverie; G Audibert; A Larcan
Journal:  Crit Care Med       Date:  1998-04       Impact factor: 7.598

4.  Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Authors:  J Briegel; H Forst; M Haller; G Schelling; E Kilger; G Kuprat; B Hemmer; T Hummel; A Lenhart; M Heyduck; C Stoll; K Peter
Journal:  Crit Care Med       Date:  1999-04       Impact factor: 7.598

5.  Measurements of serum free cortisol in critically ill patients.

Authors:  Amir H Hamrahian; Tawakalitu S Oseni; Baha M Arafah
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

6.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.